KPIRSLA Trademark

Trademark Overview


On Wednesday, July 7, 2021, a trademark application was filed for KPIRSLA with the United States Patent and Trademark Office. The USPTO has given the KPIRSLA trademark a serial number of 79319131. The federal status of this trademark filing is REGISTERED as of Tuesday, November 15, 2022. This trademark is owned by KRINGLE PHARMA, INC.. The KPIRSLA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of nerve system diseases, renal disease, respiratory system diseases, skin diseases and scar tissue
kpirsla

General Information


Serial Number79319131
Word MarkKPIRSLA
Filing DateWednesday, July 7, 2021
Status700 - REGISTERED
Status DateTuesday, November 15, 2022
Registration Number6897576
Registration DateTuesday, November 15, 2022
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 30, 2022

Trademark Statements


Certificate of Correction for RegistrationIn the statement, line 4, 567-0085 should be inserted.
Goods and ServicesPharmaceutical preparations for the treatment of nerve system diseases, renal disease, respiratory system diseases, skin diseases and scar tissue
Translation of Words in MarkThe wording "KPIRSLA" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, September 7, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKRINGLE PHARMA, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressIbaraki- shi Osaka 567-0085
JP

Party NameKRINGLE PHARMA, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressIbaraki- shi Osaka 5 567-0085
JP

Party NameKRINGLE PHARMA, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIbaraki- shi Osaka 5 567-0085
JP

Trademark Events


Event DateEvent Description
Sunday, March 27, 2022ASSIGNED TO EXAMINER
Thursday, September 2, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, September 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 11, 2021APPLICATION FILING RECEIPT MAILED
Sunday, March 27, 2022NON-FINAL ACTION WRITTEN
Monday, May 30, 2022REFUSAL PROCESSED BY IB
Monday, March 28, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, May 6, 2022REFUSAL PROCESSED BY MPU
Friday, May 6, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, July 22, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, July 22, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 28, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, July 23, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 10, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, August 30, 2022PUBLISHED FOR OPPOSITION
Tuesday, August 30, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 15, 2022REGISTERED-PRINCIPAL REGISTER
Tuesday, November 15, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Wednesday, February 15, 2023FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, March 10, 2023FINAL DISPOSITION PROCESSED
Friday, March 10, 2023FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, April 5, 2023FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, August 9, 2023TEAS SECTION 7 REQUEST RECEIVED
Monday, March 25, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Friday, April 5, 2024CORRECTION UNDER SECTION 7 - PROCESSED
Tuesday, May 14, 2024NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED